** Shares of medical device maker Teleflex TFX.N fall 8.8% to $102 premarket
** Co reports Q4 revenue of $569 million, well below analysts' average estimate of $919.3 million, according to data compiled by LSEG
** TFX posts Q4 adjusted profit of $1.91 per share vs estimates of $3.73 per share
** Co expects 2026 adjusted profit in the range of $6.25 per share to $6.55 per share, compared with estimates of $14.28 per share
** Co expects annual pre-tax savings of $48 million to $52 million in connection with a planned restructuring
** TFX said last year that it plans to divest three units from its operations for a combined value of $2.03 billion as the company sharpens its focus on critical care and hospital businesses
** TFX stock was down 8.3% YTD as of last close
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com))